Foreign-Trade Zone (FTZ) 61, Notification of Proposed Production Activity; AIAC International Pharma, LLC; (Pharmaceutical Products); Arecibo, Puerto Rico, 77952 [2023-24995]

Download as PDF khammond on DSKJM1Z7X2PROD with NOTICES 77952 Federal Register / Vol. 88, No. 218 / Tuesday, November 14, 2023 / Notices DEPARTMENT OF COMMERCE DEPARTMENT OF COMMERCE DEPARTMENT OF COMMERCE Foreign-Trade Zones Board Foreign-Trade Zones Board Bureau of Industry and Security [B–57–2023] [S–214–2023] Foreign-Trade Zone (FTZ) 61, Notification of Proposed Production Activity; AIAC International Pharma, LLC; (Pharmaceutical Products); Arecibo, Puerto Rico Foreign-Trade Zone 26; Application for Subzone; Helena Industries, LLC; Cordele, Georgia AIAC International Pharma, LLC submitted a notification of proposed production activity to the FTZ Board (the Board) for its facility in Arecibo, Puerto Rico within Subzone 61D. The notification conforming to the requirements of the Board’s regulations (15 CFR 400.22) was received on November 7, 2023. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status material(s)/ component(s) and specific finished product(s) described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board’s website—accessible via www.trade.gov/ ftz. The proposed finished product(s) and material(s)/component(s) would be added to the production authority that the Board previously approved for the operation, as reflected on the Board’s website. The proposed finished product is Janumet® XR tablets (sitagliptin and metformin hydrochloride extended release) (duty-free). The proposed foreign-status material/ component is metformin hydrochloride active pharmaceutical ingredient (dutyfree). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is December 26, 2023. A copy of the notification will be available for public inspection in the ‘‘Online FTZ Information System’’ section of the Board’s website. For further information, contact Christopher Wedderburn at Chris.Wedderburn@trade.gov. Dated: November 7, 2023. Elizabeth Whiteman, Executive Secretary. An application has been submitted to the Foreign-Trade Zones (FTZ) Board by Georgina Foreign-Trade Zone, Inc., grantee of FTZ 26, requesting subzone status for the facilities of Helena Industries, LLC, located in Cordele, Georgia. The application was submitted pursuant to the provisions of the Foreign-Trade Zones Act, as amended (19 U.S.C. 81a–81u), and the regulations of the FTZ Board (15 CFR part 400). It was formally docketed on November 8, 2023. The proposed subzone would consist of the following sites: Site 1 (33 acres) 434 Fenn Road, Cordele, Georgia; and, Site 2 (9.2 acres) 1198 Highway 280, Cordele, Georgia. A notification of proposed production activity has been submitted and is being processed under 15 CFR 400.37 (Doc. B–54–2023). The proposed subzone would be subject to the existing activation limit of FTZ 26. In accordance with the FTZ Board’s regulations, Christopher Kemp of the FTZ Staff is designated examiner to review the application and make recommendations to the Executive Secretary. Public comment is invited from interested parties. Submissions shall be addressed to the FTZ Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is December 26, 2023. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period to January 8, 2024. A copy of the application will be available for public inspection in the ‘‘Online FTZ Information Section’’ section of the FTZ Board’s website, which is accessible via www.trade.gov/ ftz. For further information, contact Christopher Kemp at Christopher.Kemp@trade.gov. Dated: November 8, 2023. Elizabeth Whiteman, Executive Secretary. [FR Doc. 2023–25050 Filed 11–13–23; 8:45 am] [FR Doc. 2023–24995 Filed 11–13–23; 8:45 am] BILLING CODE 3510–DS–P BILLING CODE 3510–DS–P VerDate Sep<11>2014 16:48 Nov 13, 2023 Jkt 262001 PO 00000 Frm 00005 Fmt 4703 Sfmt 4703 Rossiya Airlines, Pilotov St 18–4, St. Petersburg, Russia, 196210; Order Renewing Temporary Denial of Export Privileges Pursuant to section 766.24 of the Export Administration Regulations, 15 CFR parts 730–774 (‘‘EAR’’ or ‘‘the Regulations’’),1 I hereby grant the request of the Office of Export Enforcement (‘‘OEE’’) to renew the temporary denial order (‘‘TDO’’) issued in this matter on May 12, 2023. I find that renewal of this order is necessary in the public interest to prevent an imminent violation of the Regulations and that renewal for an extended period is appropriate because Rossiya Airlines (‘‘Rossiya’’) has engaged in a pattern of repeated, ongoing and/or continuous apparent violations of the EAR. I. Procedural History On May 20, 2022, I signed an order denying Rossiya’s export privileges for a period of 180 days on the ground that issuance of the order was necessary in the public interest to prevent an imminent violation of the Regulations. The order was issued ex parte pursuant to Section 766.24(a) of the Regulations and was effective upon issuance.2 The TDO was subsequently renewed on November 15, 2022 3 and again on May 12, 2023,4 in accordance with section 766.24(d) of the Regulations.5 1 On August 13, 2018, the President signed into law the John S. McCain National Defense Authorization Act for Fiscal Year 2019, which includes the Export Control Reform Act of 2018, 50 U.S.C. 4801–4852 (‘‘ECRA’’). While section 1766 of ECRA repeals the provisions of the Export Administration Act, 50 U.S.C. app. 2401 et seq. (‘‘EAA’’), (except for three sections which are inapplicable here), section 1768 of ECRA provides, in pertinent part, that all orders, rules, regulations, and other forms of administrative action that were made or issued under the EAA, including as continued in effect pursuant to the International Emergency Economic Powers Act, 50 U.S.C. 1701 et seq. (‘‘IEEPA’’), and were in effect as of ECRA’s date of enactment (August 13, 2018), shall continue in effect according to their terms until modified, superseded, set aside, or revoked through action undertaken pursuant to the authority provided under ECRA. Moreover, section 1761(a)(5) of ECRA authorizes the issuance of temporary denial orders. 50 U.S.C. 4820(a)(5). 2 The TDO was published in the Federal Register on May 25, 2022 (87 FR 31856). 3 The November 15, 2022 renewal order was published in the Federal Register on November 21, 2022 (87 FR 70780). 4 The May 12, 2023 renewal order was published in the Federal Register on May 17, 2023 (88 FR 31483). 5 At the time of the renewal, section 766.24(d) provided that BIS may seek renewal of a temporary denial order for additional 180-day renewal periods, if it believes that renewal is necessary in E:\FR\FM\14NON1.SGM 14NON1

Agencies

[Federal Register Volume 88, Number 218 (Tuesday, November 14, 2023)]
[Notices]
[Page 77952]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24995]



[[Page 77952]]

-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-57-2023]


Foreign-Trade Zone (FTZ) 61, Notification of Proposed Production 
Activity; AIAC International Pharma, LLC; (Pharmaceutical Products); 
Arecibo, Puerto Rico

    AIAC International Pharma, LLC submitted a notification of proposed 
production activity to the FTZ Board (the Board) for its facility in 
Arecibo, Puerto Rico within Subzone 61D. The notification conforming to 
the requirements of the Board's regulations (15 CFR 400.22) was 
received on November 7, 2023.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material(s)/component(s) and 
specific finished product(s) described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz. The proposed finished 
product(s) and material(s)/component(s) would be added to the 
production authority that the Board previously approved for the 
operation, as reflected on the Board's website.
    The proposed finished product is Janumet[supreg] XR tablets 
(sitagliptin and metformin hydrochloride extended release) (duty-free).
    The proposed foreign-status material/component is metformin 
hydrochloride active pharmaceutical ingredient (duty-free).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is December 26, 
2023.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Christopher Wedderburn at 
[email protected].

    Dated: November 7, 2023.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2023-24995 Filed 11-13-23; 8:45 am]
BILLING CODE 3510-DS-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.